We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Global Contrast Enhanced Ultrasound Market Driven by Demand for Early Detection of Chronic Diseases

By MedImaging International staff writers
Posted on 22 Aug 2023
Print article
Image: The contrast enhanced ultrasound market is estimated to surpass USD 2 billion by 2028 (Photo courtesy of Freepik)
Image: The contrast enhanced ultrasound market is estimated to surpass USD 2 billion by 2028 (Photo courtesy of Freepik)

Contrast-Enhanced Ultrasound (CEUS) is a non-ionizing imaging method that differs from CT scans and X-rays in its non-utilization of ionizing radiation. This inherent feature results in minimal patient risk, rendering it a safer alternative, particularly for vulnerable groups such as pregnant women, children, and those with delicate health conditions. CEUS employs contrast agents to enhance the visualization of blood flow and perfusion within bodily organs and tissues. This heightened precision in imaging soft tissues renders CEUS especially valuable for the assessment of vascular irregularities, detection of minute lesions, and characterization of tumors. CEUS stands out for its ability to provide real-time, dynamic imagery of blood circulation and tissue perfusion. This capability empowers medical professionals to immediately and interactively evaluate organ function and pathological conditions. The real-time feature proves particularly advantageous during interventional procedures, enabling physicians to accurately target and administer treatment at the moment. In comparison to imaging modalities like MRI and CT, CEUS boasts a generally more cost-effective profile, making it a viable option for healthcare systems aiming to optimize resources without compromising diagnostic precision.

The global CEUS market is projected to grow at a CAGR of 6.1% from an estimated USD 1.6 billion in 2023 to USD 2.1 billion by 2028, driven by the rising prevalence of chronic diseases and technological developments. Amidst the evolution in medical imaging technology, CEUS emerges as a safer, more accessible, and budget-friendly substitute for conventional imaging methods like CT scans and MRI. With its non-invasive characteristics and real-time imaging capacity, CEUS is bound to find increased adoption across various applications, encompassing liver and kidney imaging, vascular assessment, and the identification and characterization of tumors. Notably, the CEUS market is poised for rapid developments in contrast agents, which will improve image quality and diagnostic accuracy. Additionally, advancements in AI-powered image analysis are set to improve the interpretation and diagnosis of CEUS studies, granting healthcare practitioners the ability to make prompt and well-informed clinical judgments. Given the vast research and clinical evidence supporting the beneficial use of CEUS, regulatory authorities are likely to expand its approved applications, thereby driving greater acceptance and integration into routine medical practices. This growth in the CEUS market will ultimately translate into enhanced patient outcomes, more effective disease management, and a more patient-centric approach to medical imaging in the near future.

These are the latest findings of MarketsandMarkets (Northbrook, IL, USA), a market research firm.

Based on product, the equipment segment accounted for the highest share of the CEUS market in 2022 while the contrast agents segment is expected to register the highest CAGR over the forecast period. On the basis of application, the diagnostic applications segment accounted for the largest share of the CEUS market in 2022, while the therapeutic applications segment is expected to register the highest CAGR during the forecast period. Factors such as the introduction of novel software and the rising adoption of high-end instruments in end-user facilities will drive the growth of the therapeutic applications segment. Based on end-user, the hospital and surgical centers segment accounted for the largest share of the CEUS market in 2022, driven by the increasing geriatric population and rise in the number of hospitals. Geographically, the Asia Pacific CEUS market is anticipated to register the highest CAGR during the forecast period, driven by the expansion of manufacturing capabilities and the rise in the adoption of high-end equipment in the APAC region.

Related Links:

Gold Supplier
128 Slice CT Scanner
Supria 128
Gold Supplier
IMRT Thorax Phantom
CIRS Model 002LFC
Silver Supplier
Bucky Protector
Bucky Protector
Wireless Portable Flat Panel Detector
Saturn 8000

Print article
Sun Nuclear -    Mirion



view channel
Image: The AI model improves tumor removal accuracy during breast cancer surgery (Photo courtesy of UNC School of Medicine)

AI Model Analyzes Tumors Removed Surgically in Real-Time

During breast cancer surgery, the surgeon removes the tumor, also known as a specimen, along with a bit of the adjacent healthy tissue to ensure all cancerous cells are excised. This specimen is then X-rayed... Read more


view channel
Image: MRI screen-detected breast cancers have been found to be most often invasive cancers (Photo courtesy of 123RF)

MRI Screen-Detected Breast Cancers Are Mostly Invasive

Annual breast MRI screening is advised for patients with a lifetime breast cancer risk exceeding 20%. There exists robust data about the features of mammographic screen-detected breast cancers, although... Read more


view channel
Image: FloPatch is a revolutionary tool that facilitates real-time precision in IV fluid management in sepsis (Photo courtesy of Flosonics)

Wireless, Wearable Doppler Ultrasound Revolutionizes Precision Fluid Management in Sepsis Care

When a patient comes to the hospital with sepsis, administering intravenous (IV) fluids is usually the first course of action. However, too much IV fluid can do more harm than good, causing additional... Read more

Nuclear Medicine

view channel
Image: An AI model can evaluate brain tumors on PET (Photo courtesy of Freepik)

AI Model for PET Imaging Determines Patient Response to Brain Tumor Treatments

The assessment of changes in metabolic tumor volume (MTV) through PET scans using specific radiotracers like F-18 fluoroethyl tyrosine (FET) plays a vital role in evaluating the treatment response in patients... Read more

General/Advanced Imaging

view channel
Image: Annalise Enterprise CTB acts like a ‘second pair of eyes’ for radiologists (Photo courtesy of Annalise.ai)

Deep Learning System Boosts Radiologist Accuracy and Speed for Head CTs

Non-contrast computed tomography of the brain (NCCTB) is a commonly employed method for identifying intracranial pathology. Despite its frequent use, the complex scan outcomes are prone to being misunderstood.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.